Trial Information
Anti-[18F]FACBC PET-CT for the Characterization of Primary Prostate Cancer
Inclusion Criteria:
- Patients must be 18 years of age or older.
- Patients will be scheduled for prostatectomy based on a diagnosis of primary prostate
cancer.
- Ability to lie still for PET scanning
- Patients must be able to provide written informed consent.
Exclusion Criteria:
- Age less than 18
- Inability to lie still for PET scanning
- Cannot provide written informed consent.
- Less than 4 weeks since any prior prostate biopsy (to decrease false positive uptake
from inflammation).
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
We will investigate the ability of anti[18F]FACBC to detect primary prostate carcinoma, and to detect the primary transport mechanism for its uptake
Outcome Time Frame:
At time of scan
Safety Issue:
No
Principal Investigator
David M Schuster, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Emory University
Authority:
United States: Food and Drug Administration
Study ID:
FACBC
NCT ID:
NCT00917865
Start Date:
April 2008
Completion Date:
January 2013
Related Keywords:
- Prostate Cancers
- Prostatic Neoplasms
Name | Location |
Emory University Hospital |
Atlanta, Georgia 30322 |